Cargando…
Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
INTRODUCTION: Erythrodermic psoriasis (EP) is a rare and severe form of psoriasis that affects 1% to 2.25% of patients, increasing mortality risk. To date, very few therapies have been approved for the treatment of this condition. Recently, biological therapies that specifically target inflammatory...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AboutScience
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902433/ https://www.ncbi.nlm.nih.gov/pubmed/35309848 http://dx.doi.org/10.33393/dti.2022.2355 |